PeptideCompareSemaglutide vs Tirzepatide
How do Semaglutide and Tirzepatide compare for GLP-1 & Weight research? Side-by-side evidence, molecular profile, EU legal status and COA-verified supplier prices — never dosing advice.
At a glance
Semaglutide
Tirzepatide
Which fits which research target?
Both Semaglutide and Tirzepatide sit within GLP-1 & Weight research but are studied for different primary signals. Both exist as EMA-authorised medicines (the licensed products are not the research vials sold by vendors) — compare the evidence, not marketing claims.
What the research shows
Semaglutide
Tirzepatide
Compare prices across EU suppliers
Compare Semaglutide across EU suppliers
4 EU vendors · COA · from €64.95
Compare Tirzepatide across EU suppliers
7 EU vendors · COA · from €37.90
Frequently asked questions
Is Semaglutide or Tirzepatide better? ▾
Both exist as EMA-authorised medicines, and “better” depends on the research target. Semaglutide is most associated with Weight reduction, while Tirzepatide is studied for Weight reduction. Compare the evidence tiers and COA-verified EU pricing above rather than assuming one is superior. This is not a usage recommendation.
Why compare Semaglutide and Tirzepatide? ▾
Both are studied within GLP-1 & Weight research through different mechanisms, so researchers often weigh them against each other. This page sets their evidence, molecular profile, EU legal status and supplier pricing side by side.
Which is cheaper in the EU, Semaglutide or Tirzepatide? ▾
Prices vary by supplier, vial size and COA status. Semaglutide is listed from €64.95 across 4 COA-verified EU vendors; Tirzepatide from €37.90 across 7. Open the price pages above to compare current listings — nobody pays us for placement.